Right about now — late August into September — sea buckthorn berries are ripening across northern Europe and Asia, and the supplement marketing calendar ripens with them. The pitch usually leads with novelty: you’ve heard of omega-3s, but have you heard of omega-7?
Novelty is doing a lot of work in that sentence. Sea buckthorn is an interesting plant with a long traditional history and a handful of genuine controlled trials. It is also a case study in how “a different number after the omega” gets marketed as a discovery. Let’s sort the two.
What Sea Buckthorn Is
Sea buckthorn (Hippophae rhamnoides) is a hardy shrub whose intensely orange berries have been used in traditional preparations across Europe, Russia, China, and Central Asia for centuries. Supplements come as oil from the berry pulp, oil from the seeds, or blends of both — and the two oils differ. Pulp oil is the omega-7 source; seed oil is richer in the familiar omega-3 and omega-6 fats. Most studied products combine them.
The headline compound, palmitoleic acid (omega-7), comes with an inconvenient biochemical fact the marketing rarely mentions: it is not an essential fatty acid. Your body synthesizes it routinely from other fats. Whatever sea buckthorn may do, “correcting an omega-7 deficiency” isn’t it, because that deficiency isn’t a recognized thing. This is the same pattern we flag constantly: a real molecule, wrapped in a deficiency narrative that doesn’t survive first contact with a biochemistry textbook.
The Dry-Eye Evidence
This is sea buckthorn’s best-supported use, and it’s worth taking seriously — with sized expectations.
The key study is a randomized, double-blind, placebo-controlled trial from Finland that gave participants with dry-eye symptoms about 2 g/day of combined seed-and-pulp oil for roughly three months, spanning the cold, dry season. The sea buckthorn group showed a smaller seasonal worsening of tear-film osmolarity (a standard dry-eye severity marker) and reported less redness and burning than the placebo group. Effects were modest — this was symptom softening, not resolution — and the mechanism is presumed to involve the oil’s fatty acids and antioxidants influencing tear-film quality from the inside.
That’s one decent trial plus supportive smaller work, not a settled literature. For context, even the far larger omega-3 dry-eye evidence base delivered a famously humbling large-trial result, so a single positive sea buckthorn study warrants exactly the confidence one study deserves: some. People with persistent dry eyes should also know it’s a genuine medical condition with effective treatments — worth an optometrist visit before a supplement experiment. Our eye health overview covers where nutrients fit in the bigger picture.
The Vaginal-Dryness Evidence
The second notable trial: a randomized, placebo-controlled study in postmenopausal women gave 3 g/day of oral sea buckthorn oil for three months and assessed vaginal atrophy. The oil group showed a modestly better rate of improvement in vaginal tissue integrity than placebo, though several other measured outcomes didn’t significantly separate. Researchers framed it as a possible option for women who can’t or won’t use estrogen — a reasonable, carefully hedged conclusion for a single mid-sized study, and that hedging is worth preserving. Menopausal symptoms deserve a real medical conversation; our menopause supplement guide goes deeper on what has evidence and what doesn’t.
Everything Else: Mostly Promissory
- Skin dryness and aging: small studies and traditional use suggest possible benefits for skin hydration; controlled evidence is thin and often industry-adjacent. Plausible, unproven
- Metabolic markers: small trials on cholesterol, triglycerides, and blood sugar have produced scattered, inconsistent signals — nothing that supports taking it for cardiometabolic purposes. Purified palmitoleic-acid research is interesting at the petri-dish-and-rodent stage, which is where it should stay in your decision-making for now
- Immune and mucous-membrane claims (dry mouth, respiratory comfort): tradition-rich, trial-poor
Dose, Form, and Timing — If You Try It
- 1–2 g/day of combined seed + pulp oil matches the dry-eye research; the vaginal-dryness trial used 3 g/day. Capsules typically come as 500 mg, so that’s 2–6 daily
- Take it with a meal containing some fat, as with any oil-based supplement — covered in our supplement timing guide
- Give it a full 2–3 months — the trials ran that long, and tear-film and tissue changes are slow
- Berry powders, juices, and teas are pleasant foods, but they aren’t what was studied at these doses; topical sea buckthorn skincare is a separate product category entirely
- Expect the burps: it’s an intensely orange, tangy oil, and some people notice repeat. Freezing capsules or taking them mid-meal helps
Choosing a Product, If You Get That Far
Because “sea buckthorn” covers several distinct preparations, the label details matter more than usual:
- Check which oil you’re buying. The dry-eye trial used a combined seed and pulp oil. Pulp-only oil maximizes the omega-7 number the marketing cares about; seed-only oil barely contains any. If you’re trying to replicate the studied results, the blend is the honest match
- “Omega-7 complex” products are sometimes purified or concentrated palmitoleic acid rather than whole sea buckthorn oil — a different product resting on even thinner human evidence. The trials that exist were run on the whole oil, complex plant chemistry and all
- CO2-extracted or cold-pressed oils are standard quality markers in this category; as ever, a third-party purity test matters more than any harvesting adjective
- Expect real prices. A studied dose runs meaningful money per month. That’s worth saying out loud, because a fair comparison for dry eyes might be preservative-free artificial tears — abundant evidence, a few dollars, no capsules
And a scope note worth repeating: the modest trial evidence is for oral oil. Sea buckthorn serums, creams, and balms may be perfectly pleasant skincare, but they’re a separate bet with separate (and weaker) evidence, and nothing in the swallowed-capsule research transfers to them.
Safety and Interactions
Sea buckthorn was well tolerated in trials, with GI upset the main complaint. Cautions worth knowing:
- Blood thinners and antiplatelet drugs: sea buckthorn may have mild antiplatelet activity, so combining it with warfarin, DOACs, or daily aspirin deserves a conversation with your prescriber — and stop it a couple of weeks before scheduled surgery
- Blood pressure and blood sugar medications: limited data suggest possible additive effects; monitor rather than assume
- Pregnancy and nursing: food amounts are presumably fine; concentrated oil supplements lack safety data — skip them
- Harmless quirk: very heavy intake of the deeply pigmented berry products can tint skin slightly orange, as with any carotenoid-rich food
Bottom Line
Sea buckthorn oil earns a “modest and plausible” verdict in a category full of pure hype: one solid trial suggests 2 g/day softens dry-eye symptoms, one suggests 3 g/day helps postmenopausal vaginal dryness, and nearly everything else — skin, metabolic, immune — is tradition and early-stage research. The omega-7 deficiency framing is marketing, not biochemistry. If dry eyes or dry tissues are your issue and the basics are handled, a 2–3 month trial at studied doses is a reasonable, low-risk experiment with a defined end date.
This article is educational and not medical advice. Consult a healthcare provider before starting any supplement — especially if you’re pregnant, nursing, on medication (particularly blood thinners), or managing a medical condition.